Universal Infant Hepatitis B Vaccination programme

Cost effectiveness analysis of a universal infant hepatitis B vaccination programme in Ireland


In October 2006, the National Centre for Pharmacoeconomics conducted an economic evaluation of the cost-effectiveness of a universal hepatitis B vaccination programme, for the Health Protection Surveillance Centre/National Immunisation Advisory Committee. A summary of the main findings are available in the attached document.


Universal Infant Hepatitis B Vaccine Programme summary